FucoID Technology Platform for Identifying Tumor Antigen-Specific T Cells
FucoID Technology Platform for Identifying Tumor Antigen-Specific T Cells

Antigen specific T cells play a pivotal role in the immune response by recognizing and targeting specific pathogens or infected cells. These T cells, equipped with unique T-cell receptors, can identify and bind to particular antigens presented by major histocompatibility complex (MHC) molecules on the surface of infected or cancerous cells. The ability to harness antigen specific T cells is a promising area of research in immunotherapy, as it allows for the precise targeting of diseased cells while minimizing damage to healthy tissues. This specificity is crucial for developing effective treatments for various diseases, including cancer and infectious diseases.
What's Your Reaction?






